Development and analytical performance of a new ARCHITECT automated dipeptidyl peptidase-4 immunoassay

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) may be a suitable biomarker to identify people with severe asthma who have greater activation of the interleukin-13 (IL-13) pathway and may therefore benefit from IL-13-targeted treatments. We report the analytical performance of an Investigational Use Only...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemken, Philip M., Jeanblanc, Nicolette M., Rae, Tracey, Brophy, Susan E., Datwyler, Maria J., Xu, Ying, Manetz, T. Scott, Vainshtein, Inna, Liang, Meina, Xiao, Xiaodong, Chowdhury, Partha S., Chang, Chien-ying, Streicher, Katie, Greenlees, Lydia, Ranade, Koustubh, Davis, Gerard J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683673/
https://www.ncbi.nlm.nih.gov/pubmed/29159257
http://dx.doi.org/10.1016/j.plabm.2017.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683673/
https://www.ncbi.nlm.nih.gov/pubmed/29159257
http://dx.doi.org/10.1016/j.plabm.2017.10.003

Ejemplares similares